Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption

被引:134
|
作者
Schmidt, Sarah [1 ]
Nakchbandi, Inaam [1 ,2 ]
Ruppert, Raphael [1 ]
Kawelke, Nina [1 ,2 ]
Hess, Michael W. [3 ]
Pfaller, Kristian [3 ]
Jurdic, Pierre [4 ]
Faessler, Reinhard [1 ]
Moser, Markus [1 ]
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Univ Heidelberg, D-69120 Heidelberg, Germany
[3] Innsbruck Med Univ, Div Histol & Embryol, A-6020 Innsbruck, Austria
[4] Univ Lyon, Ecole Normale Super Lyon, F-69364 Lyon, France
来源
JOURNAL OF CELL BIOLOGY | 2011年 / 192卷 / 05期
关键词
ADHESION DEFICIENCY-III; LEUKOCYTE ADHESION; CELL FUNCTION; IN-VITRO; MICE; ACTIVATION; ORGANIZATION; PODOSOMES; KINDLINS; MATRIX;
D O I
10.1083/jcb.201007141
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The blood cell-specific kindlin-3 protein is required to activate leukocyte and platelet integrins. In line with this function, mutations in the KINDLIN-3 gene in man cause immunodeficiency and severe bleeding. Some patients also suffer from osteopetrosis, but the underlying mechanism leading to abnormal bone turnover is unknown. Here we show that kindlin-3-deficient mice develop severe osteopetrosis because of profound adhesion and spreading defects in bone-resorbing osteoclasts. Mechanistically, loss of kindlin-3 impairs the activation of beta 1, beta 2, and beta 3 integrin classes expressed on osteoclasts, which in turn abrogates the formation of podosomes and sealing zones required for bone resorption. In agreement with these findings, genetic ablation of all integrin classes abolishes the development of podosomes, mimicking kindlin-3 deficiency. Although loss of single integrin classes gives rise to podosomes, their resorptive activity is impaired. These findings show that osteoclasts require their entire integrin repertoire to be regulated by kindlin-3 to orchestrate bone homeostasis.
引用
收藏
页码:883 / 897
页数:15
相关论文
共 50 条
  • [41] Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model
    Batoon, Lena
    Millard, Susan M.
    Raggatt, Liza J.
    Wu, Andy C.
    Kaur, Simranpreet
    Sun, Lucas W. H.
    Williams, Kyle
    Sandrock, Cheyenne
    Ng, Pei Ying
    Irvine, Katharine M.
    Bartnikowski, Michal
    Glatt, Vaida
    Pavlos, Nathan J.
    Pettit, Allison R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (11) : 2214 - 2228
  • [42] OSTEOCLAST-MEDIATED OSTEOLYSIS IN BONE METASTASIS FROM RENAL-CELL CARCINOMA
    AOKI, J
    YAMAMOTO, I
    HINO, M
    SHIGENO, C
    KITAMURA, N
    SONE, T
    SHIOMI, K
    KONISHI, J
    CANCER, 1988, 62 (01) : 98 - 104
  • [43] Blockade of Osteoclast-Mediated Bone Resorption With a RANKL-Inhibitor Enhances Bone Formation in a Rat Spinal Fusion Model
    Payne, Karin A.
    Shaw, Nichole M.
    Erickson, Christopher B.
    Yarger, Peter
    Yu, Yangyi
    Baldini, Todd
    Kleck, Christopher J.
    Patel, Vikas V.
    Burger, Evalina L.
    SPINE, 2022, 47 (16) : 1165 - 1171
  • [44] Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells
    Markus Moser
    Martina Bauer
    Stephan Schmid
    Raphael Ruppert
    Sarah Schmidt
    Michael Sixt
    Hao-Ven Wang
    Markus Sperandio
    Reinhard Fässler
    Nature Medicine, 2009, 15 : 300 - 305
  • [45] Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4
    Knowles, Helen J.
    Cleton-Jansen, Anne-Marie
    Korsching, Eberhard
    Athanasou, Nicholas A.
    FASEB JOURNAL, 2010, 24 (12): : 4648 - 4659
  • [46] Role of CCN1 protein in osteoclast-mediated bone resorption after low-level cadmium
    Bhattacharyya, MH
    Valdez, M
    Tormos, K
    Agha, L
    Smith, L
    Wilson, AK
    BONE, 2006, 38 (03) : S24 - S24
  • [47] Potent and selective cathepsin L inhibitors fail to prevent human osteoclast-mediated bone resorption in vitro.
    James, IE
    Marquis, RW
    Blake, SM
    Ru, Y
    Gress, CJ
    Hwang, S
    Zembryki, D
    Tomaszek, TA
    McQueney, MS
    Bradley, BR
    Gowen, M
    Veber, DF
    Lark, MW
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S349 - S349
  • [48] Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption
    Ren, Zhong-Yuan
    Machuca-Gayet, Irma
    Domenget, Chantal
    Buchet, Rene
    Wu, Yuqing
    Jurdic, Pierre
    Mebarek, Saida
    PLOS ONE, 2015, 10 (07):
  • [49] Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption
    Violette, SM
    Guan, W
    Bartlett, C
    Smith, JA
    Bardelay, C
    Antoine, E
    Rickles, RJ
    Mandine, E
    Van Schravendijk, MR
    Adams, SE
    Lynch, BA
    Shakespeare, WC
    Yang, M
    Jacobsen, VA
    Takeuchi, CS
    Macek, KJ
    Bohacek, RS
    Dalgarno, DC
    Weigele, M
    Lesuisse, D
    Sawyer, TK
    Baron, R
    BONE, 2001, 28 (01) : 54 - 64
  • [50] The Link module from Human TSG-6 is a Potent Inhibitor of Osteoclast-Mediated Bone Resorption; Towards a Novel Therapy for Osteoporosis
    Thomson, Jennifer
    Milner, Caroline
    Day, Anthony
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28